Clorazepate, Serum or Plasma

CPT: 80299
Print Share

Synonyms

  • Tranxene® SD™
  • Tranxene® T-Tab®

Expected Turnaround Time

2 - 4 days


Related Documents


Specimen Requirements


Specimen

Serum or plasma


Volume

1 mL


Minimum Volume

0.4 mL


Container

Red-top tube, lavender-top (EDTA) tube, or green-top (heparin) tube. Do not use a gel-barrier tube. The use of gel-barrier tubes is not recommended due to slow absorption of the drug by the gel. Depending on the specimen volume and storage time, the decrease in drug level due to absorption may be clinically significant.


Collection

Transfer separated serum or plasma to a plastic transport tube. Specimen should be collected prior to next dose unless otherwise noted.


Storage Instructions

Refrigerate.


Causes for Rejection

Gel-barrier tube


Test Details


Use

Evaluate toxicity; monitor therapeutic levels


Limitations

This test was developed and its performance characteristics determined by Labcorp. It has not been cleared or approved by the Food and Drug Administration.


Methodology

Liquid chromatography/tandem mass spectrometry (LC/MS-MS)


Reference Interval

Therapeutic: 0.5−2.0 μg/mL (reported as nordiazepam)


Critical Value

Potentially toxic: >5.0 μg/mL (reported as nordiazepam)

Additional Information

The drug is used in the treatment of general anxiety disorder, the management of ethanol withdrawal, and as an adjunct anticonvulsant drug. Half-life of elimination: 40 to 50 hours. Time to peak serum: approximately one hour.


References

American Medical Association, Division of Drugs and Toxicology. Drug Evaluations Subscription. Chicago, Ill:: AMA; Summer 1991.
Drug Information Handbook. 24th ed. Hudson, OH: Wolters Kluwer Clinical Drug Information, Inc; 2015; 487.

LOINC® Map

Order Code Order Code Name Order Loinc Result Code Result Code Name UofM Result LOINC
007930 Clorazepate (Tranxene(R)), S 3498-3 007930 Clorazepate (Tranxene(R)), S ug/mL 3498-3

For Providers

Please login to order a test

Order a Test

© 2021 Laboratory Corporation of America® Holdings and Lexi-Comp Inc. All Rights Reserved.

CPT Statement/Profile Statement

The LOINC® codes are copyright © 1994-2021, Regenstrief Institute, Inc. and the Logical Observation Identifiers Names and Codes (LOINC) Committee. Permission is granted in perpetuity, without payment of license fees or royalties, to use, copy, or distribute the LOINC® codes for any commercial or non-commercial purpose, subject to the terms under the license agreement found at https://loinc.org/license/. Additional information regarding LOINC® codes can be found at LOINC.org, including the LOINC Manual, which can be downloaded at LOINC.org/downloads/files/LOINCManual.pdf